

Care Step Pathways
This section provides stand-alone Care Step Pathways (CSPs) that have been customized for the UK audience. We wish to thank Emmanouil Nikolousis, FRCP, FRCPath, PhD, MBA, Consultant Haematologist at University Hospitals Birmingham, for thoughtful review of these materials.
List of CSPs
For Immunotherapy (Checkpoint Inhibitors):
Ipilimumab
Nivolumab
Pembrolizumab
Nivolumab/Ipilimumab
- Skin Toxicities – View Online
- Gastrointestinal Toxicities (Diarrhea and Colitis) – View Online
- Thyroiditis – View Online
- Hepatitis – View Online
- Hypophysitis – View Online
- Adrenal Insufficiency, primary – View Online
- Diabetes – View Online
- Pneumonitis – View Online
- Arthralgia/Arthritis – View Online
- Mucositis/Xerostomia – View Online
- Neuropathy – View Online
- Nephritis – View Online
For Intralesional Therapy:
Talimogene laherparepvec; T-VEC
- Overall Side Effects – View Online